UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 22, 2013
|
BIO-key International, Inc. (Exact name of registrant as specified in its charter) | ||
|
Delaware (State or other jurisdiction of incorporation) |
1-13463 (Commission File Number) |
41-1741861 (I.R.S. Employer Identification No.) |
|
3349 Highway 138, Building A, Suite E Wall, NJ 07719 (Address of principal executive offices)
| ||
|
(732) 359-1100 (Registrant’s telephone number, including area code)
| ||
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c)) | ||
Item 8.01. Other Events.
On November 22, 2013, BIO-Key International, Inc. repaid in full the $497,307 principal amount secured promissory note payable to DRNC Holdings, Inc. In connection with the repayment, DRNC’s security interest in all of our tangible and intangible assets was terminated.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BIO-KEY INTERNATIONAL, INC. | ||
|
Date: November 25, 2013 |
||
|
By: |
/s/ Cecilia C. Welch | |